Get the Stockscreener App
4.71
4.85%
-0.24
After Hours:
4.71
Cns Pharmaceuticals Inc Stock (CNSP) Forecast
The Cns Pharmaceuticals Inc (CNSP) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $20.18, representing a +328.36% increase from the current price of $4.71. The highest analyst price target is $19.97, and the lowest is $20.38.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CNSP Price Target
Average 17.18
(+264.65% Upside)
Is Cns Pharmaceuticals Inc (CNSP) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 52.05 | Neutral |
| STOCH(9,6) | 24.44 | Neutral |
| STOCHRSI(14) | 23.95 | Neutral |
| MACD(12,26) | 0.7251 | Sell |
| ADX(14) | 26.06 | Buy |
| William %R | -69.99 | Neutral |
| CCI(14) | -27.36 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
6.151
Sell
|
5.3318
Sell
|
| MA20 |
4.5248
Buy
|
4.8009
Sell
|
| MA50 |
3.3081
Buy
|
4.059
Buy
|
| MA100 |
4.0914
Buy
|
4.5824
Buy
|
| MA200 |
5.7788
Sell
|
8.4852
Sell
|
Buy: 5
Sell: 5
Neutral: 0
Summary: Neutral
According to our latest analysis, CNSP could be considered a Neutral, with 17 technical analysis indicators signaling 6 Buy signals, 6 signaling Sell signals and 5 Neutral signals. This suggests that investors should exercise caution when entering new positions on CNSP, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 52.05 indicates that CNSP is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 24.44 indicates that CNSP is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 23.95 indicates that CNSP is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 26.06 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -27.36 indicates that CNSP is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term CNSP price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Cns Pharmaceuticals Inc financial reports and earnings history, Cns Pharmaceuticals Inc (CNSP) stock could reach $38.97 by 2030, $70.10 by 2040 and $319.69 by 2050. See the projected annual prices until 2050 of the Cns Pharmaceuticals Inc stock below:
- Cns Pharmaceuticals Inc (CNSP) is expected to reach an average price of $74.03 in 2035, with a high prediction of $75.20 and a low estimate of $74.62. This indicates an $1,472% rise from the last recorded price of $4.71.
- Cns Pharmaceuticals Inc (CNSP) stock is projected to chart a bullish course in 2040, with an average price target of $68.15, representing an $1,347% surge from its current level. The forecast ranges from a conservative $68.22 to a sky-high $70.10.
- Our analysts predict Cns Pharmaceuticals Inc (CNSP) to jump 640.54% by 2045, soaring from $36.04 to an average price of $34.88, potentially reaching $39.12. While $36.04 is the low estimate, the potential upside is significant.
- Cns Pharmaceuticals Inc (CNSP) stock is expected to climb by 2050, reaching an average of $319.80, a $6,690% jump from its current level. However, a wide range of estimates exists, with high and low targets of $319.69 and $322.20, respectively, highlighting the market's uncertainty.
Cns Pharmaceuticals Inc Stock (CNSP) Year by Year Forecast
Cns Pharmaceuticals Inc Stock (CNSP) Price Forecast for 2026
The predicted value for Cns Pharmaceuticals Inc (CNSP) in 2026 is set at an average of $19.55. Estimates vary from a peak of $22.86 to a trough of $16.25, indicating an +315.16% surge from the present price of $4.71.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2026 | $19.73 | $20.38 | $19.97 | +318.91% |
| July, 2026 | $20.28 | $19.98 | $19.81 | +330.62% |
| August, 2026 | $18.15 | $19.23 | $19.27 | +285.25% |
| September, 2026 | $18.86 | $17.81 | $17.52 | +300.34% |
| October, 2026 | $18.04 | $18.04 | $17.93 | +283.00% |
| November, 2026 | $16.93 | $17.20 | $17.76 | +259.41% |
| December, 2026 | $18.55 | $16.25 | $18.47 | +293.86% |
Cns Pharmaceuticals Inc Stock (CNSP) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Cns Pharmaceuticals Inc (CNSP) is $12.20, with a high forecast of $18.02 and a low forecast of $6.3775. This indicates an +158.99% increase from the last price of $4.71.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $17.43 | $17.98 | $18.02 | +270.17% |
| February, 2027 | $17.12 | $17.17 | $17.28 | +263.46% |
| March, 2027 | $16.22 | $16.51 | $16.54 | +244.41% |
| April, 2027 | $15.93 | $16.08 | $15.93 | +238.13% |
| May, 2027 | $14.17 | $14.38 | $15.63 | +200.85% |
| June, 2027 | $12.96 | $13.18 | $13.71 | +175.21% |
| July, 2027 | $11.64 | $11.88 | $12.67 | +147.06% |
| August, 2027 | $10.65 | $10.67 | $11.14 | +126.13% |
| September, 2027 | $9.5034 | $9.5634 | $10.29 | +101.77% |
| October, 2027 | $8.8375 | $8.8475 | $9.2519 | +87.63% |
| November, 2027 | $8.3816 | $8.5016 | $8.556 | +77.95% |
| December, 2027 | $6.1943 | $6.3775 | $8.0202 | +31.51% |
Cns Pharmaceuticals Inc Stock (CNSP) Price Forecast for 2028
In 2028, Cns Pharmaceuticals Inc (CNSP) is projected to reach an average price of $27.77, with a high projection of $55.28 and a low estimate of $0.2653. This indicates an +489.68% rise from the last price of $4.71.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $4.8784 | $5.2984 | $5.8848 | +3.57% |
| February, 2028 | $4.5225 | $4.584 | $4.627 | -3.98% |
| March, 2028 | $4.2152 | $4.3466 | $4.3495 | -10.50% |
| April, 2028 | $3.7112 | $3.752 | $4.0747 | -21.21% |
| May, 2028 | $2.302 | $2.4119 | $3.4206 | -51.13% |
| June, 2028 | $1.4674 | $1.476 | $2.0024 | -68.85% |
| July, 2028 | $0.5087 | $0.5201 | $1.195 | -89.20% |
| August, 2028 | $39.48 | $0.2653 | $55.28 | +738.20% |
| September, 2028 | $52.17 | $45.58 | $46.47 | +1,008% |
| October, 2028 | $49.56 | $52.86 | $50.56 | +952.14% |
| November, 2028 | $40.44 | $43.74 | $49.05 | +758.62% |
| December, 2028 | $34.23 | $37.03 | $36.04 | +626.73% |
Cns Pharmaceuticals Inc Stock (CNSP) Price Forecast for 2029
The 2029 price forecast for Cns Pharmaceuticals Inc Stock (CNSP) is $23.76 on average, with a high prediction of $44.01 and a low estimate of $3.5003. This represents an +404.40% increase from the previous price of $4.71.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $45.21 | $32.30 | $44.01 | +859.97% |
| February, 2029 | $3.2974 | $42.71 | $39.61 | -29.99% |
| March, 2029 | $24.99 | $3.5003 | $36.80 | +430.59% |
| April, 2029 | $21.78 | $16.43 | $20.28 | +362.40% |
| May, 2029 | $30.96 | $22.48 | $27.06 | +557.42% |
| June, 2029 | $33.45 | $34.95 | $32.96 | +610.25% |
| July, 2029 | $24.84 | $27.54 | $25.94 | +427.40% |
| August, 2029 | $31.03 | $29.14 | $28.93 | +558.73% |
| September, 2029 | $37.41 | $33.92 | $32.50 | +694.36% |
| October, 2029 | $33.40 | $32.31 | $30.41 | +609.12% |
| November, 2029 | $32.89 | $35.79 | $33.39 | +598.25% |
| December, 2029 | $38.08 | $33.58 | $33.88 | +708.41% |
Cns Pharmaceuticals Inc Stock (CNSP) Price Forecast for 2030
Cns Pharmaceuticals Inc Stock (CNSP) is expected to reach an average price of $47.65 in 2030, with a high forecast of $56.53 and a low forecast of $38.77. This signifies an +911.67% surge from the last price of $4.71.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $43.51 | $38.77 | $38.97 | +823.81% |
| February, 2030 | $50.28 | $45.96 | $44.69 | +967.46% |
| March, 2030 | $51.84 | $49.80 | $49.24 | +1,001% |
| April, 2030 | $57.21 | $51.57 | $56.53 | +1,115% |
| May, 2030 | $54.91 | $55.84 | $56.03 | +1,066% |
| June, 2030 | $52.00 | $53.39 | $53.04 | +1,004% |
| July, 2030 | $51.59 | $51.49 | $50.57 | +995.34% |
| August, 2030 | $48.55 | $49.63 | $50.65 | +930.85% |
| September, 2030 | $47.86 | $48.52 | $48.60 | +916.16% |
| October, 2030 | $47.16 | $47.61 | $47.33 | +901.18% |
| November, 2030 | $44.01 | $45.10 | $45.89 | +834.45% |
| December, 2030 | $42.58 | $42.67 | $43.13 | +804.10% |
2.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):